MPAA vs. PCRX

Last updated Jun 4, 2026

MPAA (Motorcar Parts of America, Inc.) and PCRX (Pacira BioSciences, Inc.) are both stocks. MPAA operates in Auto Parts (Consumer Cyclical), while PCRX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, MPAA returned -9.63%/yr vs -7.22%/yr for PCRX. At a 0.20 correlation, their price movements are largely independent.

Performance

MPAA vs. PCRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Motorcar Parts of America, Inc. (MPAA) and Pacira BioSciences, Inc. (PCRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with MPAA having a -14.51% return and PCRX slightly higher at -14.03%. Over the past 10 years, MPAA has underperformed PCRX with an annualized return of -9.63%, while PCRX has yielded a comparatively higher -7.22% annualized return.

MPAA

• 1D: -1.49%
• 1M: -5.25%
• YTD: -14.51%
• 6M: -19.59%
• 1Y: -11.34%
• 3Y*: 23.43%
• 5Y*: -15.27%
• 10Y*: -9.63%

PCRX

• 1D: -3.09%
• 1M: -8.96%
• YTD: -14.03%
• 6M: -7.56%
• 1Y: -15.21%
• 3Y*: -17.13%
• 5Y*: -18.58%
• 10Y*: -7.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MPAA vs. PCRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MPAA Motorcar Parts of America, Inc.	-14.51%	62.37%	-18.63%	-21.25%	-30.52%	-13.00%	-10.94%	32.39%	-33.41%	-7.17%
PCRX Pacira BioSciences, Inc.	-14.03%	37.37%	-44.16%	-12.61%	-35.83%	0.55%	32.10%	5.30%	-5.76%	41.33%

Correlation

The correlation between MPAA and PCRX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Feb 4, 2011	0.20

Fundamentals

Market Cap MPAA : $212.54M PCRX : $910.25M
EPS MPAA : $0.10 PCRX : $0.21
PE Ratio MPAA : 107.29 PCRX : 103.94
PS Ratio MPAA : 0.27 PCRX : 1.32
PB Ratio MPAA : 0.82 PCRX : 1.39
Total Revenue (TTM) MPAA : $770.64M PCRX : $734.86M
Gross Profit (TTM) MPAA : $148.02M PCRX : $427.72M
EBITDA (TTM) MPAA : $60.93M PCRX : $95.04M

Return for Risk

MPAA vs. PCRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MPAA

MPAA Risk / Return Rank: 34
MPAA Sharpe Ratio Rank: 33
MPAA Sortino Ratio Rank: 34
MPAA Omega Ratio Rank: 34
MPAA Calmar Ratio Rank: 33
MPAA Martin Ratio Rank: 33

PCRX

PCRX Risk / Return Rank: 22
PCRX Sharpe Ratio Rank: 22
PCRX Sortino Ratio Rank: 22
PCRX Omega Ratio Rank: 22
PCRX Calmar Ratio Rank: 24
PCRX Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MPAA vs. PCRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Motorcar Parts of America, Inc. (MPAA) and Pacira BioSciences, Inc. (PCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MPAA	PCRX	Difference
Sharpe ratio Return per unit of total volatility	-0.19	-0.41	+0.23
Sortino ratio Return per unit of downside risk	0.16	-0.35	+0.52
Omega ratio Gain probability vs. loss probability	1.02	0.96	+0.07
Calmar ratio Return relative to maximum drawdown	-0.25	-0.47	+0.22
Martin ratio Return relative to average drawdown	-0.43	-0.97	+0.53
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MPAA vs. PCRX - Sharpe Ratio Comparison

The current MPAA Sharpe Ratio is -0.19, which is higher than the PCRX Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of MPAA and PCRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MPAA	PCRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.19	-0.41	+0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.25	-0.41	+0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.18	-0.15	-0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.01	0.16	-0.14

Drawdowns

MPAA vs. PCRX - Drawdown Comparison

The maximum MPAA drawdown since its inception was -97.82%, which is greater than PCRX's maximum drawdown of -90.19%. Use the drawdown chart below to compare losses from any high point for MPAA and PCRX.

Drawdown Indicators

	MPAA	PCRX	Difference
Max Drawdown Largest peak-to-trough decline	-97.82%	-90.19%	-7.63%
Max Drawdown (1Y) Largest decline over 1 year	-46.31%	-29.61%	-16.70%
Max Drawdown (3Y) Largest decline over 3 years	-53.34%	-71.53%	+18.19%
Max Drawdown (5Y) Largest decline over 5 years	-82.71%	-85.67%	+2.96%
Max Drawdown (10Y) Largest decline over 10 years	-86.63%	-85.67%	-0.96%
Current Drawdown Current decline from peak	-73.79%	-81.34%	+7.55%
Average Drawdown Average peak-to-trough decline	-51.31%	-50.01%	-1.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.20%	14.37%	+11.83%

Volatility

MPAA vs. PCRX - Volatility Comparison

Motorcar Parts of America, Inc. (MPAA) and Pacira BioSciences, Inc. (PCRX) have volatilities of 9.86% and 10.11%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MPAA	PCRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.86%	10.11%	-0.25%
Volatility (6M) Calculated over the trailing 6-month period	33.37%	28.70%	+4.67%
Volatility (1Y) Calculated over the trailing 1-year period	61.52%	37.07%	+24.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.98%	45.60%	+15.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	54.45%	46.91%	+7.54%

Dividends

MPAA vs. PCRX - Dividend Comparison

Neither MPAA nor PCRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

MPAA vs. PCRX - Profitability Comparison

The chart below illustrates the profitability comparison between Motorcar Parts of America, Inc. and Pacira BioSciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MPAA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported a gross profit of 32.88M and revenue of 167.70M. Therefore, the gross margin over that period was 19.6%.

PCRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a gross profit of 0.00 and revenue of 177.38M. Therefore, the gross margin over that period was 0.0%.

MPAA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported an operating income of 8.33M and revenue of 167.70M, resulting in an operating margin of 5.0%.

PCRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported an operating income of 6.90M and revenue of 177.38M, resulting in an operating margin of 3.9%.

MPAA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Motorcar Parts of America, Inc. reported a net income of 1.78M and revenue of 167.70M, resulting in a net margin of 1.1%.

PCRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a net income of 7.08M and revenue of 177.38M, resulting in a net margin of 4.0%.

Frequently Asked Questions

Can I hold both MPAA and PCRX in my portfolio?

MPAA and PCRX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MPAA or PCRX?

PCRX has higher volatility (10.11%) compared to MPAA (9.86%). In terms of maximum drawdown, MPAA dropped -97.82% vs PCRX's -90.19%.

Which has better risk-adjusted returns?

MPAA currently has the higher Sharpe Ratio (-0.19 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.